Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Journal of Neurology

Volumn 256, Issue 7, 2009, Pages 1052-1060

  Krone, Bernd ^a,d   Oeffner, Frank ^b   Grange, John M ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d Laboratory Medicine Institute Kassel   (Germany)

Author keywords

Common infections; Endogenous retroviruses; Epstein Barr virus; Hygiene hypothesis; Immunologic network; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS;

ANIMALS; CAUSALITY; COMORBIDITY; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; HYGIENE; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, REGULATORY; VACCINES;

EID: 67650470976     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5068-8     Document Type: Review

References (64)

1. H Lassmann W Brück CF Lucchinetti 2007 The immunopathology of multiple sclerosis: an overview Brain Pathol 17 210 218 10.1111/j.1750-3639. 2007.00064.x
2. G Giovanni G Ebers 2007 Multiple sclerosis: the environment and causation Curr Opin Neurol 20 261 268 (Pubitemid 46743106)
3. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part I: the role of infection Ann Neurol 61 288 299 10.1002/ana.21117
4. A Ascherio KL Munger 2007 Environmental risk factors for multiple sclerosis. Part II: non-infectious factors Ann Neurol 61 504 513 10.1002/ana.21141
5. The International Multiple sclerosis Genetics Consortium 2007 Risk alleles for multiple sclerosis identified by a genome wide study N Engl J Med 357 851 862 10.1056/NEJMoa073493
6. J Fleming Z Fabry 2007 The hygiene hypothesis and multiple sclerosis Ann Neurol 61 85 88 10.1002/ana.21092
7. JL Stanford CA Stanford JM Grange 2001 Environmental echoes Sci Prog 84 Part 2 105 124 10.3184/003685001783239014
8. A Pfahlberg KF Kölmel JM Grange G Mastrangelo B Krone IN Botev 2002 Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study J Invest Dermatol 119 570 575 10.1046/j.1523-1747.2002.00643.x
9. KF Kölmel JM Grange B Krone G Mastrangelo CR Rossi BM Henz 2005 Prior immunization of patients with malignant melanoma with vaccinia or BCG is associated with a better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients Eur J Cancer 41 118 125 10.1016/j.ejca.2004.09.023
10. B Krone KF Kölmel BM Henz JM Grange 2005 Protection against melanoma by vaccination with Bacille Calmette-Guérin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control Eur J Cancer 41 104 117 10.1016/j.ejca.2004.08.010
11. G Mastrangelo B Krone E Fadda JM Grange A Buja E de Vries 2009 Does yellow fever 17D vaccine protect against melanoma? Vaccine 27 588 591 10.1016/j.vaccine.2008.10.076
12. B Krone D Pohl K Rostasy E Kahler E Brunner F Oeffner 2008 Common infectious agents in multiple sclerosis: a case control study in children Mult Scler 14 136 139 10.1177/1352458507082069
13. D Pohl B Krone K Rostasy E Kahler E Brunner M Lehnert 2006 High seroprevalence of Epstein-Barr virus in children with multiple sclerosis Neurology 67 2063 2065 10.1212/01.wnl.0000247665.94088.8d
14. B Banwell L Krupp J Kennedy R Tellier S Tenebaum J Ness 2007 Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study Lancet Neurol 6 773 781 10.1016/S1474-4422(07) 70196-5
15. Haahr S, Höllsberg P (2001) The ability of candidate viruses to explain the epidemiological findings in multiple sclerosis. In: Hommes OR, Clanet M, Wekerle H (eds) Genes and viruses in multiple sclerosis. Elsevier Science, Amsterdam, pp 163-184
16. S Haahr P Höllsberg 2006 Multiple sclerosis is linked to Epstein-Barr virus infection Rev Med Virol 16 297 310 10.1002/rmv.503
17. G Giovannoni GR Cutter J Lünemann R Martin C Münz S Sriam 2006 Infectious causes of multiple sclerosis Lancet Neurol 5 887 894 10.1016/S1474-4422(06)70577-4
18. GN DeLorenze KL Munger ET Lennette N Orentreich JH Vogelman A Ascherio 2006 Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Arch Neurol 63 839 844 10.1001/archneur.63.6.noc50328
19. A Ascherio KL Munger ET Lennette D Spiegelman MA Hernán MJ Olek 2001 Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study JAMA 286 3083 3088 10.1001/jama.286.24.3083 (Pubitemid 34016522)
20. S Haahr AM Plesner BF Vestergaard P Höllsberg 2004 A role of late Epstein-Barr virus infection in multiple sclerosis Acta Neurol Scand 109 270 275 10.1046/j.1600-0404.2003.00221.x
21. LI Levin KL Munger MV Rubertone CA Peck ET Lennette D Spiegelman 2003 Multiple sclerosis and Epstein-Barr virus JAMA 289 1533 1536 10.1001/jama.289.12.1533
22. EL Thacker F Mirzaei A Ascherio 2006 Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis Ann Neurol 59 499 503 10.1002/ana.20820
23. JD Lünemann P Huppke S Roberts W Brück J Gärtner C Münz 2008 Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis Neurology 71 1033 1035 10.1212/01.wnl.0000326576. 91097.87
24. Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR (2008) Decreased T-cell reactivity to Epstein-Barr virus-infected lymphoblastoid cell lines in multiple sclerosis. J Neurosurg Psychiatry (Epub ahead of print). doi: 10.1136/jnnp.2008.161018
25. LI Levin KL Munger MV Rubertone CA Peck ET Lennette D Spiegelman 2005 Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis JAMA 293 2469 2500 10.1001/jama.293.20.2496
26. PG Bagos G Nikolopoulos A Ioannidis 2006 Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta analysis Mult Scler 12 397 411 10.1191/1352458506ms1291oa
27. SD Cook C Rohowsky-Kochan S Bansil PC Dowling 1995 Evidence for multiple sclerosis as an infectious disease Acta Neurol Scand Suppl 161 34 42
28. S-K Kim RM Welsh 2004 Comprehensive early and lasting loss of memory CD8 T cells and functional memory during acute and persistent viral infections J Immunol 172 3139 3150 (Pubitemid 38263704)
29. Y Belkaid 2007 Regulatory T cells and infection: a dangerous necessity Nat Rev Immunol 7 875 888 10.1038/nri2189
30. P Höllsberg M Kusk E Bech HJ Hansen J Jacobsen S Haahr 2005 Presence of Epstein-Barr virus and human herpes virus 6B in multiple sclerosis: association with clinical activity Acta Neurol Scand 112 395 402 10.1111/j.1600-0404.2005.00516.x
31. R Alvarez-Lafuente M Garcia-Montojo V De Las Heras MI Dominguez-Mozo M Bartolome MS Benito-Martin 2008 Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients Mult Scler 14 595 601 10.1177/1352458507086425
32. H Perron F Lazarini K Ruprecht C Péchoux-Longin D Seilhean V Sazdovich 2005 Human endogenous retroviruses (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis J Neurovirol 11 22 33
33. G Mameli V Astone G Arru S Marconi L Lovato C Serra 2007 Brains and peripheral blood mononuclear cells of multiple sclerosis patients hyperexpress MS-associated retroviruses, but not human herpesvirus 6 J Gen Virol 88 264 274 10.1099/vir.0.81890-0
34. + T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis Clin Exp Immunol 132 137 143 10.1046/j.1365-2249.2003. 02114.x
35. S Cepok D Zhou R Srivastava Stei S Nessler K Büssow 2005 Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis J Clin Invest 115 1352 1360 (Pubitemid 40629055)
36. JD Lünemann N Edwards PA Muraro S Hayashi JI Cohen C Münz 2006 Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T cells in multiple sclerosis Brain 129 1493 1506 10.1093/brain/awl067
37. JD Lünemann I Jelcic S Roberts A Lutterotti B Tackenberg R Martin 2008 EBNA1-specific T-cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 J Exp Med 205 1763 1772 10.1084/jem.20072397
38. F Gronen K Ruprecht B Weissbrich E Klinker A Kroner HH Hofstetter 2006 Frequency analysis of HLA-B27-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls J Neuroimmunol 180 185 192 10.1016/j.jneuroim.2006.08.008
39. KS Voo T Fu HE Heslop MK Brenner CM Rooney RF Wang 2002 Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells Cancer Res 62 7195 7199 (Pubitemid 36025237)
40. + regulatory T cells in patients with multiple sclerosis J Exp Med 199 971 979 10.1084/jem.20031579
41. + T-cell-response in patients with early multiple sclerosis Brain 131 1712 1721 10.1093/brain/awn108
42. SF Altschul W Gish W Miller DJ Lipman 1990 Basic local alignment search tool J Mol Biol 215 403 410
43. Kuttler C, Nussbaum AK, Dick TP, Rammensee HG, Schild H, Hadeler KP (2000) An algorithm for the prediction of proteasomal cleavages. J Mol Biol 298:417-429. Erratum in J Mol Biol 2000; 301:229. doi: 10.1006/jmbi.2000.3683
44. reg dysfunction in multiple sclerosis J Immunol 179 1322 1330
45. Dolei A, Perron H (2008) The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics and immunology in human physiology and disease. J Neurovirol Nov 27:1-10 (Epub ahead of print)
46. A Tai E O'Reilly K Alroy K Simon K Munger B Huber 2008 Human endogenous retrovirus-K 18 Env as a risk factor in multiple sclerosis Mult Scler 14 1175 1180 10.1177/1352458508094641
47. Rammensee HG, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219. http://www.syfpeithi.de. doi: 10.1007/s002510050595 (Pubitemid 30099526)
48. Sibley WA (2001) The effect of virus-like infections on the course of multiple sclerosis. In: Hommes OR, Clanet M, Wekerle H (eds) Genes and viruses in multiple sclerosis. Elsevier Science B. V, Amsterdam, pp 92-98
49. AL Ponsonby I van der Mei T Dwyer L Blizzard B Taylor A Kemp 2005 Exposure to infant siblings during early life and risk of multiple sclerosis JAMA 293 439 463 10.1001/jama.293.4.463
50. AD Sadovnick IML Lee GC Ebers the Canadian Collaborative Study Group 2005 Multiple sclerosis and birth order: a longitudinal cohort study Lancet Neurol 4 611 617 10.1016/S1474-4422(05)70170-8
51. J Correale M Farez 2007 Association between parasite infection and immune responses in multiple sclerosis Ann Neurol 61 97 108 10.1002/ana.21067
52. + regulatory T cells J Immunol 179 958 966
53. MJ Chao MC Barnardo MR Lincoln SV Ramagopalan BM Herrera DA Dyment 2008 HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility Proc Natl Acad Sci USA 105 13069 13074 10.1073/pnas.0801042105
54. K Ritter R Härtl G Bandlow R Thomssen 1986 Cytostatic effect of gangliosides present in the membrane of macrophages Cell Immunol 97 248 256 10.1016/0008-8749(86)90395-3
55. H Nojiri S Kitagawa M Nakamura K Kirito Y Enomoto M Saito 1988 Neolacto-series gangliosides induce granulocytic differentiation of human promyelotic leukaemia cell line HL-60 J Biol Chem 263 7443 7446 (Pubitemid 18147027)
56. E Garcion L Sindji G Leblondel P Brachet F Darcy 1999 1, 25-Dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase amd glutathione levels in primary rat astrocytes J Neurochem 73 859 866 10.1046/j.1471-4159.1999.0730859.x
57. L Schaade M Kleines R Walter R Thomssen 1999 A membrane-located glycoshingolipid of monocyte/granulocyte lineage cells induces growth arrest and triggers the lytic cycle in Epstein-Barr virus genome positive Burkitt-lymphoma lines Microbiol Immunol 188 23 29 10.1007/s004300050101
58. L Schaade M Kleines B Krone M Hausding R Walter K Ritter 2000 Enhanced transcription of the S-adenosylhomocystein hydrolase gene precedes Epstein-Barr virus lytic gene activation in ganglioside stimulated lymphoma cells Microbiol Immunol 189 13 18 10.1007/PL00008252 (Pubitemid 30727440)
59. B Serafini B Rosicarelli D Franciotta R Magliozzi R Reynolds P Cinque 2007 Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain J Exp Med 204 2899 2912 10.1084/jem.20071030
60. D Franciotta M Salvetti F Lolli B Serafini F Aloisi 2008 B cells and multiple sclerosis Lancet Neurol 7 852 858 10.1016/S1474-4422(08)70192-3
61. O Torkildson H Nyland H Myrmel KM Myhr 2008 Epstein-Barr virus reactivation and multiple sclerosis Eur J Neurol 15 106 108 (Pubitemid 350265290)
62. J Lindsey L Hatfield M Crawford S Patel 2009 Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis Mult Scler 15 153 158
63. DJ Miller M Rodriguez 1995 A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes J Immunol 154 2460 2469
64. GA Rook JL Stanford 1998 Give us this day our daily germs Immunol Today 19 113 116 10.1016/S0167-5699(97)01204-8